Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. [electronic resource]
Producer: 20040317Description: 496-9 p. digitalISSN:- 0003-4975
- Cardiopulmonary Bypass
- Cause of Death
- Coronary Disease -- surgery
- Enzyme Inhibitors -- administration & dosage
- Female
- Heart Valve Diseases -- surgery
- Hemodynamics -- drug effects
- Humans
- Hypotension -- drug therapy
- Infusions, Intravenous
- Male
- Methylene Blue -- administration & dosage
- Middle Aged
- Nitric Oxide -- antagonists & inhibitors
- Postoperative Complications -- drug therapy
- Risk Factors
- Survival Rate
- Systemic Inflammatory Response Syndrome -- drug therapy
- Vascular Resistance -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.